CS_Orphan Drug Designation_3
1 March 2018
Pharmablue
Did you like this article? Share on social networks:
1 March 2018
Pharmablue
Did you like this article? Share on social networks:
Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...
Known as Expanded Access Programs in the US, early access programs (EAP) allow access to...
Main benefits of outsourcing "Exploitant" status : Reminder : French regulatory authorities require having an...